Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Steroids and Hyaluronidase for Vocal Fold Lesions
NCT06854380Phase 1Recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of betamethasone and hyaluronidase in Benign vocal fold lesion (BVFL), sponsored by Mansoura University. Primary endpoint: Grade, Roughness, Breathiness, Asthenia, Strain Scale at 3 months. Started Jan 2026; status: recruiting.
02
Drugs
betamethasonehyaluronidase
03
Conditions
Benign vocal fold lesion (BVFL)
Beyond the preview
Go deeper on NCT06854380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06854380.